These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 28120750)

  • 1. [Polymer nanoparticles for the delivery of anticancer drug].
    Nicolas J; Couvreur P
    Med Sci (Paris); 2017 Jan; 33(1):11-17. PubMed ID: 28120750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
    Luo C; Sun J; Sun B; He Z
    Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.
    Huynh NT; Roger E; Lautram N; Benoît JP; Passirani C
    Nanomedicine (Lond); 2010 Nov; 5(9):1415-33. PubMed ID: 21128723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smart synthetic polymer nanocarriers for controlled and site-specific drug delivery.
    Balaure PC; Grumezescu AM
    Curr Top Med Chem; 2015; 15(15):1424-90. PubMed ID: 25877097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.
    Nicolas J; Mura S; Brambilla D; Mackiewicz N; Couvreur P
    Chem Soc Rev; 2013 Feb; 42(3):1147-235. PubMed ID: 23238558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supramolecular nanoscale assemblies for cancer diagnosis and therapy.
    Coelho SC; Pereira MC; Juzeniene A; Juzenas P; Coelho MAN
    J Control Release; 2015 Sep; 213():152-167. PubMed ID: 26160308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
    Bhunchu S; Rojsitthisak P
    Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
    Li C; Ge X; Wang L
    Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
    Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
    Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlling and Monitoring Intracellular Delivery of Anticancer Polymer Nanomedicines.
    Battistella C; Klok HA
    Macromol Biosci; 2017 Oct; 17(10):. PubMed ID: 28444959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymer nanoparticles for the intravenous delivery of anticancer drugs: the checkpoints on the road from the synthesis to clinical translation.
    Ferrari R; Sponchioni M; Morbidelli M; Moscatelli D
    Nanoscale; 2018 Dec; 10(48):22701-22719. PubMed ID: 30512025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual nanoparticle drug delivery: the future of anticancer therapies?
    King MR; Mohamed ZJ
    Nanomedicine (Lond); 2017 Jan; 12(2):95-98. PubMed ID: 27885896
    [No Abstract]   [Full Text] [Related]  

  • 13. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A vision for cyclodextrin nanoparticles in drug delivery systems and pharmaceutical applications.
    Lakkakula JR; Maçedo Krause RW
    Nanomedicine (Lond); 2014 May; 9(6):877-94. PubMed ID: 24981652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphiphilic hyper-branched co-polymer nanoparticles for the controlled delivery of anti-tumor agents.
    Miao Q; Xu D; Wang Z; Xu L; Wang T; Wu Y; Lovejoy DB; Kalinowski DS; Richardson DR; Nie G; Zhao Y
    Biomaterials; 2010 Oct; 31(28):7364-75. PubMed ID: 20599267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications.
    Fleige E; Quadir MA; Haag R
    Adv Drug Deliv Rev; 2012 Jun; 64(9):866-84. PubMed ID: 22349241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymer nanoparticulate drug delivery and combination cancer therapy.
    Cao P; Bae Y
    Future Oncol; 2012 Nov; 8(11):1471-80. PubMed ID: 23148619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinational drug delivery using nanocarriers for breast cancer treatments: A review.
    Olov N; Bagheri-Khoulenjani S; Mirzadeh H
    J Biomed Mater Res A; 2018 Aug; 106(8):2272-2283. PubMed ID: 29577607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Drug Delivery System for Platinum-based Anticancer Drugs.
    Gao C; Zhang Y; Chen J; Wang T; Qian Y; Yang B; Dong P; Zhang Y
    Mini Rev Med Chem; 2016; 16(11):872-91. PubMed ID: 26586124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Delivery Vehicles Based on Albumin-Polymer Conjugates.
    Jiang Y; Stenzel M
    Macromol Biosci; 2016 Jun; 16(6):791-802. PubMed ID: 26947019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.